Trader’s Watch List: Ryerson Holding Corporation Com (NYSE:RYI), InterCloud Systems (NASDAQ:ICLD), Ligand Pharmaceuticals (NASDAQ:LGND), Hemispherx Biopharma (NYSEMKT:HEB), Independence Realty Trust (NYSEMKT:IRT)

On Friday shares of Ryerson Holding Corporation Com (NYSE:RYI) closed at $7.80. Company’s sales growth for last 5 years was 3.40% and EPS growth for next 5 years is recorded as 10.00%. Ryerson Holding Corporation Com (NYSE:RYI), named CFO Edward Lehner its next president and chief executive, effective June 1. Mr. Lehner will succeed CEO Michael Arnold, who plans to retire at the end of May.

InterCloud Systems, Inc. (NASDAQ:ICLD) in last trading activity advanced 17.51% to close at $3.96. Company weekly performance is 48.31% while its quarterly performance stands at 35.62%. InterCloud Systems, Inc. (NASDAQ:ICLD) is -49.81% away from its 52 week high. InterCloud Systems, Inc. (NASDAQ:ICLD) will hold a conference call to discuss its financial results for the First Quarter 2015. CEO Mark Munro and CFO Tim Larkin will participate in the call, which is scheduled for Wednesday May 13, 2015, at 10:00 a.m. Eastern time (7:00 a.m. Pacific).

On Friday shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) closed at $80.51. Company’s sales growth for last 5 years was 10.60% and EPS growth for next 5 years is recorded as 45.97%. Ligand Pharmaceuticals Inc. (NASDAQ:LGND) reported that first-quarter net income declined to $0.75 million or $0.04 per share from $2.10 million or $0.10 per share in the prior-year quarter.

Hemispherx Biopharma, Inc. (NYSEMKT:HEB) in last trading activity decreased -1.56% to close at $0.25. Company weekly performance is -2.69% while its quarterly performance stands at 5.42%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) is -36.75% away from its 52 week high. On May 11, NYSEMKT:HEB announces that its European subsidiary, Hemispherx Biopharma Europe N.V./S.A., received formal notification from the European Commission approving its Orphan Medicinal Product Application for Ampligen®, an experimental therapeutic, to treat Ebola Virus Disease (EVD).

On last trading day Independence Realty Trust, Inc. (NYSEMKT:IRT) decreased -1.27% to close at $8.57. Its volatility for the week is 4.26% while volatility for the month is 2.10%. IRT’s EPS growth for past 5 years was 18.50%. Independence Realty Trust, Inc. (NYSEMKT:IRT) monthly performance is -9.59%. Independence Realty Trust, Inc. (NYSEMKT:IRT) and Trade Street Residential, Inc. jointly announced that IRT and TSRE have signed a definitive merger agreement pursuant to which IRT has agreed to acquire all of the outstanding common stock of Trade Street for a mix of cash and stock, creating a leading, regional market focused, multifamily REIT.

Leave a Reply

Your email address will not be published. Required fields are marked *

*